drugset / Trial / NCT07233655
A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is ongoing to explore the efficacy and safety of different strengths of SHR-3045 injection in moderate to severe active rheumatoid arthritis.
Timeline
- Start
- 2026-01-19
- Primary completion
- 2026-04-21
- Completion
- 2026-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHR-3045 | Unknown | — | — |